Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05851976 · ClinicalTrials.gov registry record · Phase 4

Duloxetine for LBP

A Phase 4 study of Back Pain, Low, sponsored by Montefiore Medical Center.

Recruiting
Registry status
Phase 4
Development phase
120
Enrollment target
1
Study location

NCT05851976: Recruiting Phase 4 study of Back Pain, Low, sponsored by Montefiore Medical Center.

NCT05851976 is a Phase 4 study of Back Pain, Low that is actively recruiting participants, run by Montefiore Medical Center. The registered enrollment target is 120 participants, below the 237-participant average among 5 other Back Pain, Low trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05851976, a Phase 4 study of Back Pain, Low, is actively recruiting participants, sponsored by Montefiore Medical Center.

RECRUITING
Registry status
Phase 4
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

This research study will help determine whether a medication called duloxetine can improve back pain. It is well documented that many participants who come to the ER with acute low back pain still have low back pain 3 months later. The investigator team will attempt to determine whether duloxetine can help prevent this.

Primary Outcome

An ordinal pain scale ("severe", "moderate", "mild", or "none") will be used to assess LBP. Study participants will be asked to describe their worst back pain over the previous 24 hours. The number of patients reporting with "Moderate" or "Severe" pain will be summarized by study arm.

Conditions Studied

Interventions

  • DRUG Duloxetine
  • DRUG Naproxen

Study Locations (1)

New York

  • Montefiore Medical Center - The Bronx

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2023-10-04
Est. Completion 2027-05
Phase Phase 4
Montefiore Medical Center

345 total trials

What NCT05851976 shows while recruiting

NCT05851976 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 237-participant average among 5 other Back Pain, Low trials with a reported enrollment target (49% lower).

The record links to 1 condition, with Back Pain, Low appearing as the primary indexed condition, and to 2 interventions - of which Duloxetine is the first listed.

NCT05851976 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05851976 about?

NCT05851976 is a clinical study titled "Duloxetine for LBP". This research study will help determine whether a medication called duloxetine can improve back pain. It is well documented that many participants who come to the ER with acute low back pain still have low back pain 3 months later. The investigator team will attempt to determine whether duloxetine c...

What is the current status of trial NCT05851976?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 120 participants. The study started on 2023-10-04. Estimated completion is 2027-05.

What conditions does trial NCT05851976 study?

This clinical trial studies the following conditions: Back Pain, Low.

What interventions are being tested in trial NCT05851976?

The interventions under investigation include: Duloxetine (DRUG), Naproxen (DRUG).

Who is sponsoring clinical trial NCT05851976?

This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05851976 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Back Pain, Low

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05851976, the US trial registry maintained by the National Library of Medicine. NCT05851976 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.